These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
115 related items for PubMed ID: 10437880
1. "Inactive" polymer is active against sexually transmitted diseases. Larkin M. Lancet; 1999 Jul 31; 354(9176):399. PubMed ID: 10437880 [No Abstract] [Full Text] [Related]
2. [The acceptability on vaginal microbicides to prevent human immunodeficiency virus/sexually transmitted diseases]. Han L, Wu ZL. Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb 31; 30(2):196-8. PubMed ID: 19565887 [No Abstract] [Full Text] [Related]
3. Challenges of introducing vaginal microbicides in India. Joshi S, Kulkarni V, Paranjape R, Chandhiok N. Indian J Med Res; 2009 May 31; 129(5):618-9. PubMed ID: 19675395 [No Abstract] [Full Text] [Related]
4. Microbicides: putting women in control. Forbes A. WORLD; 1998 Sep 31; (89):4-5. PubMed ID: 11365770 [Abstract] [Full Text] [Related]
5. Microbicides and other topical agents in the prevention of HIV and sexually transmitted infections. Nikolic DS, Garcia E, Piguet V. Expert Rev Anti Infect Ther; 2007 Feb 31; 5(1):77-88. PubMed ID: 17266456 [Abstract] [Full Text] [Related]
6. Delivering on MPTs: addressing the needs, rising to the challenges and making the opportunities. Malcolm RK, Fetherston SM. Contraception; 2013 Sep 31; 88(3):321-5. PubMed ID: 23890794 [No Abstract] [Full Text] [Related]
7. Design of a "microbicide" for prevention of sexually transmitted diseases using "inactive" pharmaceutical excipients. Neurath AR, Strick N, Li YY, Lin K, Jiang S. Biologicals; 1999 Mar 31; 27(1):11-21. PubMed ID: 10441398 [Abstract] [Full Text] [Related]
8. Microbicide for prevention of sexually transmitted diseases using a pharmaceutical excipient. Neurath AR. AIDS Patient Care STDS; 2000 Apr 31; 14(4):215-9. PubMed ID: 10806641 [Abstract] [Full Text] [Related]
9. Microbicides for the prevention of sexually transmitted HIV infection. Karim QA, Baxter C. Expert Rev Anti Infect Ther; 2013 Jan 31; 11(1):13-23. PubMed ID: 23428099 [Abstract] [Full Text] [Related]
10. Appropriateness of hydroxyethylcellulose gel as a placebo control in vaginal microbicide trials: a comparison of the two control arms of HPTN 035. Richardson BA, Kelly C, Ramjee G, Fleming T, Makanani B, Roberts S, Musara P, Mkandawire N, Moench T, Coletti A, Soto-Torres L, Karim SA, HPTN 035 Study Team. J Acquir Immune Defic Syndr; 2013 May 01; 63(1):120-5. PubMed ID: 23334506 [Abstract] [Full Text] [Related]
11. Acceptability of a non-woven device for vaginal drug delivery of microbicides or other active agents. Joanis CL, Hart CW. AIDS Behav; 2010 Jun 01; 14(3):600-6. PubMed ID: 20049522 [Abstract] [Full Text] [Related]
12. A randomized controlled safety trial of the diaphragm and cellulose sulfate microbicide gel in sexually active women in Zimbabwe. van der Straten A, Napierala S, Cheng H, Mauck C, Depineres T, Dhlakama P, Thompson M, Chipato T, Hammond N, Padian N. Contraception; 2007 Nov 01; 76(5):389-99. PubMed ID: 17963865 [Abstract] [Full Text] [Related]
13. 'We need a microbicide now!'. Smart T. IAPAC Mon; 2006 Apr 01; 12(4):114. PubMed ID: 17233098 [No Abstract] [Full Text] [Related]
14. Unacceptable side-effects associated with a hyperosmolar vaginal microbicide in a phase 1 trial. Lacey CJ, Woodhall S, Qi Z, Sawant S, Cowen M, McCormack S, Jiang S. Int J STD AIDS; 2010 Oct 01; 21(10):714-7. PubMed ID: 21139151 [Abstract] [Full Text] [Related]
16. A cause for optimism: microbicides pipeline shows promise. McCord A. Proj Inf Perspect; 2008 Sep 01; (46):24-5. PubMed ID: 19048680 [No Abstract] [Full Text] [Related]
17. Safety trial of the vaginal microbicide cellulose sulfate gel in HIV-positive men. Jespers V, Buvé A, Van Damme L. Sex Transm Dis; 2007 Jul 01; 34(7):519-22. PubMed ID: 17297382 [Abstract] [Full Text] [Related]
18. The slow evolution of microbicides for STD/HIV prevention. Howes J, Bass M. J Gend Specif Med; 1999 Jul 01; 2(3):22-3. PubMed ID: 11252848 [No Abstract] [Full Text] [Related]
19. A review of current intravaginal drug delivery approaches employed for the prophylaxis of HIV/AIDS and prevention of sexually transmitted infections. Ndesendo VM, Pillay V, Choonara YE, Buchmann E, Bayever DN, Meyer LC. AAPS PharmSciTech; 2008 Jul 01; 9(2):505-20. PubMed ID: 18431651 [Abstract] [Full Text] [Related]
20. Research. Spun cloth may provide another option for HIV protection. AIDS Policy Law; 2013 Jan 01; 28(3):3. PubMed ID: 23476951 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]